Amanote Research
Register
Sign In
HER2 Signaling Modulates the Equilibrium Between Pro- And Antiangiogenic Factors via Distinct Pathways: Implications for HER2-targeted Antibody Therapy
Oncogene
- United Kingdom
doi 10.1038/sj.onc.1209685
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Genetics
Molecular Biology
Date
May 22, 2006
Authors
X-F Wen
G Yang
W Mao
A Thornton
J Liu
R C Bast
X-F Le
Publisher
Springer Science and Business Media LLC
Related search
Targeted Therapy for HER2 Positive Breast Cancer
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Frequent PTEN Loss and Differential HER2/PI3K Signaling Pathway Alterations in Salivary Duct Carcinoma: Implications for Targeted Therapy
Cancer
Cancer Research
Oncology
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
Cancer Cell
Cancer Research
Oncology
Cell Biology
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
Cancer Cell
Cancer Research
Oncology
Cell Biology
A Central Role for HER3 in HER2-Amplified Breast Cancer: Implications for Targeted Therapy
Cancer Research
Cancer Research
Oncology
Plasma HER2 (ERBB2) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal Cancer
Clinical Cancer Research
Cancer Research
Oncology
The Tumor Immunosuppressive Microenvironment Impairs the Therapy of Anti-Her2/Neu Antibody
Protein & Cell
Biochemistry
Biotechnology
Drug Discovery
Cell Biology
Medicine
Determining Duration of HER2-Targeted Therapy Using Stem Cell Extinction Models
PLoS ONE
Multidisciplinary
Ultrasmall Targeted Nanoparticles With Engineered Antibody Fragments for Imaging Detection of HER2-overexpressing Breast Cancer
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
